NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 88 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 110.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $172,000 | +258.3% | 336,414 | +305.6% | 0.01% | +400.0% |
| Q1 2017 | $48,000 | +380.0% | 82,943 | +449.8% | 0.00% | – |
| Q4 2016 | $10,000 | -78.7% | 15,086 | -83.0% | 0.00% | -100.0% |
| Q2 2016 | $47,000 | -65.9% | 88,831 | -14.7% | 0.00% | -50.0% |
| Q4 2015 | $138,000 | +53.3% | 104,085 | +85.2% | 0.00% | 0.0% |
| Q2 2015 | $90,000 | +34.3% | 56,207 | +33.1% | 0.00% | +100.0% |
| Q1 2015 | $67,000 | +204.5% | 42,244 | +259.6% | 0.00% | – |
| Q4 2014 | $22,000 | -78.8% | 11,747 | -83.3% | 0.00% | -100.0% |
| Q2 2014 | $104,000 | +30.0% | 70,153 | +63.4% | 0.00% | +100.0% |
| Q1 2014 | $80,000 | +33.3% | 42,932 | +48.1% | 0.00% | 0.0% |
| Q4 2013 | $60,000 | -52.8% | 28,996 | -39.5% | 0.00% | -50.0% |
| Q3 2013 | $127,000 | – | 47,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|